608 related articles for article (PubMed ID: 34530732)
1. Circuit imaging biomarkers in preclinical and prodromal Parkinson's disease.
Meles SK; Oertel WH; Leenders KL
Mol Med; 2021 Sep; 27(1):111. PubMed ID: 34530732
[TBL] [Abstract][Full Text] [Related]
2. Characterizing the heterogeneous metabolic progression in idiopathic REM sleep behavior disorder.
Han X; Wu P; Alberts I; Zhou H; Yu H; Bargiotas P; Yakushev I; Wang J; Höglinger G; Förster S; Bassetti C; Oertel W; Schwaiger M; Huang SC; Cumming P; Rominger A; Jiang J; Zuo C; Shi K
Neuroimage Clin; 2020; 27():102294. PubMed ID: 32570206
[TBL] [Abstract][Full Text] [Related]
3. Four-Year Follow-up of [
Kogan RV; Janzen A; Meles SK; Sittig E; Renken RJ; Gurvits V; Mayer G; Leenders KL; Oertel WH;
Mov Disord; 2021 Jan; 36(1):230-235. PubMed ID: 32909650
[TBL] [Abstract][Full Text] [Related]
4. FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder.
Meles SK; Vadasz D; Renken RJ; Sittig-Wiegand E; Mayer G; Depboylu C; Reetz K; Overeem S; Pijpers A; Reesink FE; van Laar T; Heinen L; Teune LK; Höffken H; Luster M; Kesper K; Adriaanse SM; Booij J; Leenders KL; Oertel WH
Mov Disord; 2017 Oct; 32(10):1482-1486. PubMed ID: 28734065
[TBL] [Abstract][Full Text] [Related]
5. Correlations between dopaminergic dysfunction and abnormal metabolic network activity in REM sleep behavior disorder.
Huang Z; Jiang C; Li L; Xu Q; Ge J; Li M; Guan Y; Wu J; Wang J; Zuo C; Yu H; Wu P
J Cereb Blood Flow Metab; 2020 Mar; 40(3):552-562. PubMed ID: 30741074
[TBL] [Abstract][Full Text] [Related]
6. From Rapid Eye Movement Sleep Behavior Disorder to Parkinson's Disease: Possible Predictive Markers of Conversion.
Zhou L; Zhu L; Liu J
ACS Chem Neurosci; 2019 Feb; 10(2):824-827. PubMed ID: 30222303
[TBL] [Abstract][Full Text] [Related]
7. Brain Glucose Metabolism Heterogeneity in Idiopathic REM Sleep Behavior Disorder and in Parkinson's Disease.
Arnaldi D; Meles SK; Giuliani A; Morbelli S; Renken RJ; Janzen A; Mayer G; Jonsson C; Oertel WH; Nobili F; Leenders KL; Pagani M;
J Parkinsons Dis; 2019; 9(1):229-239. PubMed ID: 30741687
[TBL] [Abstract][Full Text] [Related]
8. Altered sensorimotor cortex noradrenergic function in idiopathic REM sleep behaviour disorder - A PET study.
Andersen KB; Hansen AK; Sommerauer M; Fedorova TD; Knudsen K; Vang K; Van Den Berge N; Kinnerup M; Nahimi A; Pavese N; Brooks DJ; Borghammer P
Parkinsonism Relat Disord; 2020 Jun; 75():63-69. PubMed ID: 32480309
[TBL] [Abstract][Full Text] [Related]
9. Network degeneration in Parkinson's disease: multimodal imaging of nigro-striato-cortical dysfunction.
Ruppert MC; Greuel A; Tahmasian M; Schwartz F; Stürmer S; Maier F; Hammes J; Tittgemeyer M; Timmermann L; van Eimeren T; Drzezga A; Eggers C
Brain; 2020 Mar; 143(3):944-959. PubMed ID: 32057084
[TBL] [Abstract][Full Text] [Related]
10. Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study.
Simuni T; Uribe L; Cho HR; Caspell-Garcia C; Coffey CS; Siderowf A; Trojanowski JQ; Shaw LM; Seibyl J; Singleton A; Toga AW; Galasko D; Foroud T; Tosun D; Poston K; Weintraub D; Mollenhauer B; Tanner CM; Kieburtz K; Chahine LM; Reimer A; Hutten SJ; Bressman S; Marek K;
Lancet Neurol; 2020 Jan; 19(1):71-80. PubMed ID: 31678032
[TBL] [Abstract][Full Text] [Related]
11. The Metabolic Pattern of Idiopathic REM Sleep Behavior Disorder Reflects Early-Stage Parkinson Disease.
Meles SK; Renken RJ; Janzen A; Vadasz D; Pagani M; Arnaldi D; Morbelli S; Nobili F; Mayer G; Leenders KL; Oertel WH;
J Nucl Med; 2018 Sep; 59(9):1437-1444. PubMed ID: 29476004
[TBL] [Abstract][Full Text] [Related]
12. Brain Metabolic Correlates of Dopaminergic Denervation in Prodromal and Early Parkinson's Disease.
Kim R; Kim H; Kim YK; Yoon EJ; Nam HW; Jeon B; Lee JY
Mov Disord; 2022 Oct; 37(10):2099-2109. PubMed ID: 36250497
[TBL] [Abstract][Full Text] [Related]
13. Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study.
Iranzo A; Tolosa E; Gelpi E; Molinuevo JL; Valldeoriola F; Serradell M; Sanchez-Valle R; Vilaseca I; Lomeña F; Vilas D; Lladó A; Gaig C; Santamaria J
Lancet Neurol; 2013 May; 12(5):443-53. PubMed ID: 23562390
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers in Parkinson's disease (recent update).
Sharma S; Moon CS; Khogali A; Haidous A; Chabenne A; Ojo C; Jelebinkov M; Kurdi Y; Ebadi M
Neurochem Int; 2013 Sep; 63(3):201-29. PubMed ID: 23791710
[TBL] [Abstract][Full Text] [Related]
15. Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson's disease.
Doppler K; Jentschke HM; Schulmeyer L; Vadasz D; Janzen A; Luster M; Höffken H; Mayer G; Brumberg J; Booij J; Musacchio T; Klebe S; Sittig-Wiegand E; Volkmann J; Sommer C; Oertel WH
Acta Neuropathol; 2017 Apr; 133(4):535-545. PubMed ID: 28180961
[TBL] [Abstract][Full Text] [Related]
16. Changes in network activity with the progression of Parkinson's disease.
Huang C; Tang C; Feigin A; Lesser M; Ma Y; Pourfar M; Dhawan V; Eidelberg D
Brain; 2007 Jul; 130(Pt 7):1834-46. PubMed ID: 17470495
[TBL] [Abstract][Full Text] [Related]
17. Functional imaging in pre-motor Parkinson's disease.
Arnaldi D; Morbelli S; Picco A; Ferrara M; Buschiazzo A; Famà F; De Carli F; Nobili F
Q J Nucl Med Mol Imaging; 2014 Dec; 58(4):366-75. PubMed ID: 25366709
[TBL] [Abstract][Full Text] [Related]
18. Imaging of the nigrostriatal system for evaluating the preclinical phase of Parkinson's disease development: the utility of neuromelanin, diffusion MRI, and DAT-SPECT.
Takahashi H; Kashiwagi N; Arisawa A; Matsuo C; Kato H; Adachi H; Kajiyama Y; Mochizuki H; Tomiyama N
Br J Radiol; 2022 Feb; 95(1130):20210837. PubMed ID: 34808066
[TBL] [Abstract][Full Text] [Related]
19. Cerebral glucose metabolism in idiopathic REM sleep behavior disorder is different from tau-related and α-synuclein-related neurodegenerative disorders: A brain [18F]FDG PET study.
Liguori C; Ruffini R; Olivola E; Chiaravalloti A; Izzi F; Stefani A; Pierantozzi M; Mercuri NB; Modugno N; Centonze D; Schillaci O; Placidi F
Parkinsonism Relat Disord; 2019 Jul; 64():97-105. PubMed ID: 30930059
[TBL] [Abstract][Full Text] [Related]
20. Multimodal dopamine transporter (DAT) imaging and magnetic resonance imaging (MRI) to characterise early Parkinson's disease.
Porter E; Roussakis AA; Lao-Kaim NP; Piccini P
Parkinsonism Relat Disord; 2020 Oct; 79():26-33. PubMed ID: 32861103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
